CyberKnife – 10 years of Treating Men with Prostate Cancer
October 13, 2023
Since our beginning in 1996, The Urology Group has built a strong reputation for being the premier place for men in the Tristate to have prostate cancer treatment. While we as a nation we are still facing the odds of 1 out of 8 men getting this disease, if caught early, prostate cancer is quite curable. That’s why annual visits to your urologist are so important. A quick, painless blood test can go a long way in keeping prostate cancer at bay.
In 2013 we introduced CyberKnife radiation to our prostate cancer toolbox. The treatment is delivered in our Norwood headquarters in a special suite we designed for these patients. During that 10-year span we have treated more than 3,200 men, some traveling thousands of miles for this specialized approach.
This non-invasive treatment typically means men receive a fraction of the treatment sessions (usually about 5) than they would with other radiation (normally about 40). While CyberKnife is not appropriate for everyone with prostate cancer, it has helped thousands of men, and we think that’s a reason to celebrate.
We would like to thank the dedicated team who takes great care of these patients:
Dr. Peter Fried – Radiation oncologist and Medical Director for Radiation Services
Greater Cincinnatians might not know this as they plunk down their credit cards to pay for Sweetest Day gifts this month (taking place October 18), but the holiday was founded in Ohio. Around 1922, candymaker Herbert Birch Kingston, a candymaker in Cleveland, dreamed up the day as a way to bring happiness to others. READ the…
The incidence rate for prostate cancer in the state of Ohio is greater than the national average – 123.4 cases per every 100,000 men, compared with 118.3 nationally. This does not mean the prostate cancer prognosis for Ohio men is less positive, however. In fact, most men diagnosed with prostate cancer in 2025 should expect…
What’s nearly as big as the U.S. condom market? The erectile dysfunction (ED) drug market – and it’s getting even bigger. The U.S. ED drug market generated nearly $1.4 billion in sales in 2024, and by 2030 it’s expected to net close to $2.2 billion. A lot of that growth can be attributed to the…